Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 58,164 | 30,193 | 34,735 | 18,312 | 7,848 |
| Operating Income | -58,164 | -30,193 | -34,735 | -18,312 | -7,848 |
| Interest Expense | 0 | 749 | 906 | 665 | 769 |
| Other Income | 2,244 | 4,385 | -2,000 | -498 | 97 |
| Pre-tax Income | -55,919 | -26,557 | -37,641 | -19,475 | -8,520 |
| Income Tax | 5 | 10 | 4 | 7 | 2 |
| Net Income Continuous | -55,925 | -26,567 | -37,645 | -19,482 | -8,522 |
| Net Income | $-55,925 | $-26,567 | $-37,645 | $-19,482 | $-8,522 |
| EPS Basic Total Ops | -1.41 | -0.73 | -5.37 | -8.77 | -5.00 |
| EPS Basic Continuous Ops | -1.41 | -0.73 | -5.37 | -8.77 | -5.24 |
| EPS Diluted Total Ops | -1.41 | -0.73 | -5.37 | -8.77 | -5.00 |
| EPS Diluted Continuous Ops | -1.41 | -0.73 | -5.37 | -8.77 | -5.24 |
| EPS Diluted Before Non-Recurring Items | -1.41 | -0.85 | -5.37 | -10.00 | -5.00 |
| EBITDA(a) | $-57,440 | $-29,295 | $-34,281 | $-17,707 | $-7,220 |